Literature DB >> 17228076

Targeting drug-eluting stents to lesions at high risk of restenosis: a flawed approach?

A K Siotia, A C Morton, S Mofidi, C Wales, C Newman, J Gunn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17228076      PMCID： PMC1861370          DOI： 10.1136/hrt.2006.089243

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

1.  Drug eluting stents: maximising benefit and minimising cost.

Authors:  J Gunn; A C Morton; C Wales; C M H Newman; D C Crossman; D C Cumberland
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

2.  Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.

Authors:  Adnan Kastrati; Alban Dibra; Julinda Mehilli; Sandra Mayer; Susanne Pinieck; Jürgen Pache; Josef Dirschinger; Albert Schömig
Journal:  Circulation       Date:  2006-05-08       Impact factor: 29.690

3.  Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators.

Authors:  P N Ruygrok; R Melkert; M A Morel; J A Ormiston; F W Bär; F Fernandez-Avilès; H Suryapranata; K D Dawkins; C Hanet; P W Serruys
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

4.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.